Brain stimulation and probiotics for diarrhea-predominant IBS
Part of Digestive system clinical trials.
This trial tests whether combining a type of brain stimulation (repetitive transcranial magnetic stimulation) with a probiotic tablet can help people with diarrhea-predominant irritable bowel syndrome. It aims to improve symptoms by targeting both the brain and the gut.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with diarrhea-predominant IBS based on the Rome IV criteria.
- You are between 18 and 70 years old.
- Your IBS symptoms have lasted for at least 6 months.
- You have not taken any IBS medications (except for emergencies) for at least 2 weeks before starting the trial.
- You are not currently participating in any other research studies.
- You do not have severe liver, kidney, heart, blood, or brain diseases, and you do not have a psychiatric condition that affects your thinking or memory.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether repeated magnetic stimulation applied to the scalp (a non-invasive procedure) can reduce diarrhea and belly pain in people with diarrhea-predominant IBS. The goal is to see if this brain-based treatment can improve your symptoms.
This trial studies fecal microbiota transplantation, which is transferring stool bacteria from a healthy donor to help rebalance gut microbes. If you have irritable bowel syndrome (IBS) that hasn’t improved after several standard treatments, this study may see whether it reduces your symptoms and is safe.
This study tests whether fecal microbiota transplantation (a stool-based treatment to change gut bacteria) can reduce symptoms of irritable bowel syndrome (IBS) that comes with diarrhea. You may be eligible if you’re an adult with diarrhea-predominant IBS and recent colonoscopy results that rule out other intestinal diseases.
This study tests whether a fecal microbiota transplant (FMT) — transferring healthy stool bacteria into your gut — can help people with severe irritable bowel syndrome (IBS) that hasn't improved after trying at least two other treatments.
This trial tests a new treatment called SMT04 for people with irritable bowel syndrome (IBS), specifically the diarrhea or mixed types. It may help reduce symptoms like abdominal pain and changes in bowel habits.
This study tests whether transferring stool bacteria from a healthy donor (fecal microbiota transplantation) can improve symptoms of irritable bowel syndrome (IBS). It may help by changing the gut bacteria that can influence digestion and gut discomfort.
Hear when a new Irritable Bowel Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.